Kurs
+6,79%
Prenumeration
Kalender
Est. tid* | ||
2026-04-23 | N/A | Årsstämma |
2026-04-23 | 07:30 | Kvartalsrapport 2026-Q1 |
2026-02-12 | 07:30 | Bokslutskommuniké 2025 |
2025-10-22 | 07:30 | Kvartalsrapport 2025-Q3 |
2025-07-23 | 07:30 | Kvartalsrapport 2025-Q2 |
2025-04-25 | - | X-dag ordinarie utdelning SECARE 0.25 SEK |
2025-04-24 | - | Årsstämma |
2025-04-24 | - | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-10-23 | - | Kvartalsrapport 2024-Q3 |
2024-07-25 | - | Kvartalsrapport 2024-Q2 |
2024-04-26 | - | X-dag ordinarie utdelning SECARE 0.23 SEK |
2024-04-25 | - | Årsstämma |
2024-04-25 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-10-25 | - | Kvartalsrapport 2023-Q3 |
2023-07-27 | - | Kvartalsrapport 2023-Q2 |
2023-05-02 | - | X-dag ordinarie utdelning SECARE 0.22 SEK |
2023-04-28 | - | Årsstämma |
2023-04-28 | - | Kvartalsrapport 2023-Q1 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-10-27 | - | Kvartalsrapport 2022-Q3 |
2022-10-19 | - | Extra Bolagsstämma 2022 |
2022-07-28 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-04-29 | - | X-dag ordinarie utdelning SECARE 0.20 SEK |
2022-04-28 | - | Årsstämma |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-10-28 | - | Kvartalsrapport 2021-Q3 |
2021-07-29 | - | Kvartalsrapport 2021-Q2 |
2021-05-24 | - | Split SECARE 1:5 |
2021-04-30 | - | X-dag ordinarie utdelning SECARE 0.80 SEK |
2021-04-29 | - | Årsstämma |
2021-04-29 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-09-11 | - | Extra Bolagsstämma 2020 |
2020-07-24 | - | Kvartalsrapport 2020-Q2 |
2020-04-22 | - | X-dag ordinarie utdelning SECARE 0.70 SEK |
2020-04-21 | - | Årsstämma |
2020-04-21 | - | Kvartalsrapport 2020-Q1 |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-10-24 | - | Kvartalsrapport 2019-Q3 |
2019-07-26 | - | Kvartalsrapport 2019-Q2 |
2019-04-26 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
2019-04-25 | - | Årsstämma |
2019-04-25 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-10-25 | - | Kvartalsrapport 2018-Q3 |
2018-07-27 | - | Kvartalsrapport 2018-Q2 |
2018-04-26 | - | Kvartalsrapport 2018-Q1 |
2018-04-25 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
2018-04-24 | - | Årsstämma |
2018-02-22 | - | Bokslutskommuniké 2017 |
2017-10-26 | - | Kvartalsrapport 2017-Q3 |
2017-08-25 | - | Kvartalsrapport 2017-Q2 |
2017-04-28 | - | X-dag ordinarie utdelning SECARE 0.00 SEK |
2017-04-27 | - | Årsstämma |
2017-04-27 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-10-27 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Pet MD Brands, a subsidiary of Swedencare AB (publ) ("Swedencare"), has acquired the American brand, Riley's. The total purchase price, on a cash- and debt free basis, is 7.5 million USD (78.4 million SEK) and paid through a cash settlement to the seller. Through this acquisition, Swedencare has established a presence in the fast-growing organic treats market for dogs in the United States. The deal has been completed in two steps; 30% was acquired at the beginning of Q4 2023 with an option to buy the remaining 70% in H1 2024. Swedencare has elected to exercise and close on the option today, January 2nd, 2024. The transaction has been financed from operating cash flow and has not affected Swedencare’s ability to make quarterly amortizations on its long-term loans.
An initial joint test launch of Riley's products took place in Pet MD's Amazon channel beginning in January 2023, resulting in over 2 million USD of Riley’s sales growth in this channel.
Riley's net revenue was approximately 3.2 million USD during the last fiscal year (January 2023 – December 2023).
”Through the acquisition of Riley’s, we have now entered the fast-growing organic treat market in North America. Pet parents have made organic pet treats one of the fastest growth categories and entering this category will allow Swedencare to utilize the Pet MD Brands team and technology to accelerate the excellent above industry growth both Riley’s and Pet MD Brands have seen throughout 2023. We see exciting opportunities to quickly add Riley’s high quality, organic, and premium products and cross-sell into the U.S. Veterinary and the U.S. Pet Retail markets through our existing North American brands. In addition, we are exploring expanding the range internationally through other Swedencare subsidiaries.” says Brian Nugent, CCO of Swedencare North America.
For more information, please contact:
Håkan Lagerberg, CEO Swedencare
Phone: +46 (0)73 517 01 70
Email: hakan.lagerberg@swedencare.se
Jenny Graflind, CFO Swedencare
Phone: +46 (0)73 944 85 54
Email: jenny.graflind@swedencare.se
FNCA is the Certified Adviser of the Company
Please visit the Company homepage www.swedencare.com
About Swedencare
Swedencare, a listed company on NASDAQ First North Growth Market, specializes in pet healthcare and produces, markets and sells premium products in the global and fast-growing market. The company has a wide range of strong brands and products within most therapy areas, including Animal Pharmaceuticals®, Nutravet®, NutriScience, Pet MD®, Stratford®, VetWELL®, NaturVet® as well as ProDen PlaqueOff® for oral health to dogs and cats. Swedencare’s headquarter is in Malmö, Sweden with subsidiaries located in nine countries with products sold in more than sixty countries. Swedencare’s sales have increased significantly over the last few years with strong margins and profits.
About Riley's Pets
Riley's Pets, through its primary brand Riley's®, is a leading supplier of organic and premium treats for dogs, with some products containing only single-sourced ingredients, such as dehydrated chicken, sweet potato, and turkey tendons. For more product information, visit www.rileyspets.com.